CN100588420C - A kind of Chinese medicinal formulae of orally taken for curing leukocytopenia - Google Patents
A kind of Chinese medicinal formulae of orally taken for curing leukocytopenia Download PDFInfo
- Publication number
- CN100588420C CN100588420C CN200710114451A CN200710114451A CN100588420C CN 100588420 C CN100588420 C CN 100588420C CN 200710114451 A CN200710114451 A CN 200710114451A CN 200710114451 A CN200710114451 A CN 200710114451A CN 100588420 C CN100588420 C CN 100588420C
- Authority
- CN
- China
- Prior art keywords
- grams
- leukocytopenia
- curing
- chinese medicinal
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicinal formulae of orally taken for curing leukocytopenia, it is characterized in that, making the raw materials of effective components medicine by following weight is: Caulis Spatholobi 30 grams, Fructus Psoraleae 10 grams, Poria 10 grams, Fructus Amomi 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Fructus Lycii 10 grams, Radix Angelicae Sinensis 10 grams, the Radix Astragali 20 grams, Radix Codonopsis 15 grams.1 dose of every day, day clothes 3 times, 2 weeks were a course of treatment.The present invention treats leukopenia, and effect is remarkable, and lasting medicine, has no adverse reaction and side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicinal formulae of orally taken for curing leukocytopenia, belong to the field of Chinese medicines.
Background technology
Leukopenia means in the surrounding hemogram that total white blood cells continues to be lower than 4.0 * 109/L person.Modern medicine thinks and both is found in secondary person also have partly cause not clear.Granulocytopenia can have heritability, familial, acquired etc., wherein acquired occupying the majority.Medicine, lonizing radiation, infection, toxin etc. all can make granulocytopenia, and the medicine causer is the most common.Patient can be asymptomatic or nonspecific symptom is arranged, and goes down as weak, poor appetite, muscle power, and the easy infection tendency is arranged.Whether concurrent infection is looked the granulocytopenia degree.Infection site is seen with lung, urinary tract, skin etc. more.
Doctor trained in Western medicine certain curative effect is arranged, but after drug withdrawal, leukocyte tends to fall again with adenine phosphate, batilol, leucogen and hormonal medicaments treatment.The Chinese traditional treatment primary disease has accumulated certain experience, carry out under the principle of determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs instructs, differential diagnosis of diseases combines with dialectical, neither lost system tcm characteristic, absorbed the achievement in research of modern medicine again, this is the major reason that this condition of disease of Chinese traditional treatment improves constantly curative effect.Compare with doctor trained in Western medicine, the Chinese medicine primary disease, not only short term effect is satisfied, and also consolidation of late result, thereby has certain advantage.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicinal formulae of orally taken for curing leukocytopenia, it can overcome the deficiency of Chinese and western medicine in the leukopenia therapeutic process, and it is obvious to be used for the treatment of the leukopenia effect.
The present invention is achieved through the following technical solutions: the Chinese medicinal formulae of this kind orally taken for curing leukocytopenia, it is characterized in that, making the raw materials of effective components medicine by following weight is: Caulis Spatholobi 30 grams, Fructus Psoraleae 10 grams, Poria 10 grams, Fructus Amomi 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Fructus Lycii 10 grams, Radix Angelicae Sinensis 10 grams, the Radix Astragali 20 grams, Radix Codonopsis 15 grams.
Usage: 1 dose of every day, day clothes 3 times, 2 weeks were a course of treatment.
Pharmacological action:
Caulis Spatholobi: blood circulation promoting and blood stasis dispelling, it is warm in nature, bitter in the mouth, sweet is returned liver, kidney channel. have enrich blood, invigorate blood circulation, the effect of collateral dredging.
Fructus Psoraleae: reinforcing the kidney and supporting YANG.Control the cold diarrhea of suffering from a deficiency of the kidney, the enuresis, spermatorrhea, frequent micturition, sexual impotence, chills and pain of the waist and kness, deficiency and coldness is breathed heavily and is coughed.
Poria: eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Control dysuria, the edema distension, the phlegm retention cough with dyspnea, the sound of vomiting of vomitting is had loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful.
Fructus Amomi: during circulation of qi promoting was transferred, stomach function regulating was amusing.Control the stomachache painful abdominal mass and expand anorexia dyspepsia, dysphagic vomiting, diarrhea due to cold pathogen cold-dysentery, pregnant fetal movement.
The Rhizoma Atractylodis Macrocephalae: spleen reinforcing, stomach reinforcing, dampness and in.Control deficient QI of the spleen and stomach, anorexia asthenia weak breath, deficiency-distension is had loose bowels, edema, jaundice, arthralgia chiefly caused by damp pathogen, dizziness, spontaneous perspiration.
Fructus Lycii: nourishing kidney, lung moistening, tonifying liver makes eye bright, and calms the nerves.
Radix Angelicae Sinensis: sweet Wen Zhirun, be the key medicine of enriching blood, enrich blood and invigorate blood circulation, holding concurrently again can dispersing cold for relieving pain.
The Radix Astragali: tonifying Qi and lifting yang, benefit are defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent.Cure mainly weakness of the spleen and stomach, lack of appetite asthenia, deficiency of vital energy blood prostration, exterior deficiency spontaneous perspiration, night sweat.
Radix Codonopsis: invigorating the spleen and replenishing QI, promote the production of body fluid, nourish blood.Be used for the empty asthenia of body of deficiency of QI in middle-JIAO, lung qi loses empty cough and asthma, and the two shallow complexions of losing of QI and blood, dizzy cardiopalmus etc.
The present invention treats leukopenia, and effect is remarkable, and lasting medicine, has no adverse reaction and side effect.Model case is as follows:
Case one: poplar, the woman, 45 years old, people from Sichuan, patient be because of pale complexion, and be dizzy weak, and movable back shortness of breath and palpitation 1 year is surplus.Hemogram: leukocyte 1.7 * 109/L, hemoglobin 52g/L, platelet is 18 * 109/L, through taking we after half a year, hemogram: leukocyte 4.2 * 109/L, hemoglobin 98g/L, platelet is 86 * 109/L, the patient is in, and still uses our Drug therapy.
Case two: beam, woman, 57 years old, certain secondary school teachers, patient's pale complexion, gingival hemorrhage one month, hemogram: leukocyte (WBC) 2.1 * 109/L, hemoglobin (HB) 49g/L, platelet (PLT) is 16 * 109/L, take we treatment 4 courses of treatment after, leukocyte (WBC) 3.5 * 109/L, hemoglobin (HB) 88g/L, platelet (PLT) is 70 * 109/L, keeps treatment so far.
Case three: the Wang, the man, 52 years old, people from Hunan, patient's gingival hemorrhage, epistaxis is many January, is idiopathic thrombocytopenic purpura at certain hospital diagnosis.Hemogram: leukocyte (WBC) 2.49 * 109/L, hemoglobin (HB) 64g/L, platelet (PLT) is 24 * 109/L, takes we's treatment after 2 months, the complete blood cell bottom out, bleeding is obviously alleviated, and is existing still in treatment.
The specific embodiment
Example one: a kind of Chinese medicinal formulae of orally taken for curing leukocytopenia, make the raw materials of effective components medicine and be: Caulis Spatholobi 30 grams, Fructus Psoraleae 10 grams, Poria 10 grams by following weight, Fructus Amomi 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Fructus Lycii 10 grams, Radix Angelicae Sinensis 10 grams, the Radix Astragali 20 grams, Radix Codonopsis 15 grams.
Usage: 1 dose of every day, day clothes 3 times, 2 weeks were a course of treatment.
Claims (1)
1, a kind of Chinese medicinal formulae of orally taken for curing leukocytopenia is characterized in that, makes the raw materials of effective components medicine by following weight to be: Caulis Spatholobi 30 grams, Fructus Psoraleae 10 grams, Poria 10 grams, Fructus Amomi 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Fructus Lycii 10 grams, Radix Angelicae Sinensis 10 grams, the Radix Astragali 20 grams, Radix Codonopsis 15 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710114451A CN100588420C (en) | 2007-11-21 | 2007-11-21 | A kind of Chinese medicinal formulae of orally taken for curing leukocytopenia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710114451A CN100588420C (en) | 2007-11-21 | 2007-11-21 | A kind of Chinese medicinal formulae of orally taken for curing leukocytopenia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101181584A CN101181584A (en) | 2008-05-21 |
| CN100588420C true CN100588420C (en) | 2010-02-10 |
Family
ID=39447097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710114451A Expired - Fee Related CN100588420C (en) | 2007-11-21 | 2007-11-21 | A kind of Chinese medicinal formulae of orally taken for curing leukocytopenia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100588420C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104324145A (en) * | 2014-11-24 | 2015-02-04 | 毛艳玲 | Traditional Chinese medicine for treating leukopenia and agranulocytosis |
-
2007
- 2007-11-21 CN CN200710114451A patent/CN100588420C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 放化疗后白细胞减少症的中医药研究进展. 呼健等.河北中医，第25卷第2期. 2003 |
| 放化疗后白细胞减少症的中医药研究进展. 呼健等.河北中医，第25卷第2期. 2003 * |
| 白细胞减少症的中医治疗进展. 侯丕华等.中日友好医院学报 ，第14卷第3期. 2000 |
| 白细胞减少症的中医治疗进展. 侯丕华等.中日友好医院学报，第14卷第3期. 2000 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101181584A (en) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101485865B (en) | Chinese medicine fat-reducing plaster | |
| CN101195015A (en) | Chinese medicine for treating barrenness | |
| CN102579897A (en) | Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof | |
| CN104645136A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
| CN102366541A (en) | Traditional Chinese medicine composition for treatment of diabetes | |
| CN101085290B (en) | Oral administration traditional Chinese medicine composition for treating diabetes insipidus | |
| CN101181412B (en) | Chinese medicine prescription orally taken for curing leukocytopenia | |
| CN100588420C (en) | A kind of Chinese medicinal formulae of orally taken for curing leukocytopenia | |
| CN101468129A (en) | Chinese medicinal composition for treating chronic nephritis | |
| CN101401891B (en) | Traditional Chinese medicine decoction for treating aplastic anemia | |
| CN101791348B (en) | Traditional Chinese medicine preparation for treating deficiency disease | |
| CN104524153A (en) | Traditional Chinese medicine composition for treating perimenopausal female urethral syndrome | |
| CN1895357A (en) | Chinese medicine for treating kidney insufficiency | |
| CN102626502A (en) | Traditional Chinese medicinal composition for treating mammary gland hyperplasia | |
| CN102580030A (en) | External traditional Chinese medicine composition having effect of reducing blood sugar, preparation prepared from the external traditional Chinese medicine composition, and their preparation method | |
| CN101204495B (en) | Peroral Chinese traditional medicine composition for chronic nephritis | |
| CN106110237A (en) | A kind of decoction medicine treating angina pectoris and preparation method thereof | |
| CN101904938A (en) | Kidney-tonifying heath traditional Chinese medicine composition and preparation method thereof | |
| CN101455780A (en) | Oral traditional Chinese medicine prescription for treating diabetes | |
| CN1879801A (en) | An externally applied Chinese medicinal bag for relieving pain | |
| CN101125171B (en) | Reinforced traditional Chinese medicine for male and female | |
| CN1660383A (en) | Preparation of Chinese traditional medicine for treating sterility of woman caused by blockage of oviduct and preparation method | |
| CN109091570A (en) | A kind of Chinese medicine for treating chorionitis | |
| CN101199720B (en) | Chinese medicine compound for oral administration for treating chronicity nephritis | |
| CN103182035B (en) | Traditional Chinese medicine composition used for treating chronic arrhythmia of elderly people and preparation method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100210 Termination date: 20101121 |